DOI:
10.1055/s-00000173
Neuroradiologie Scan
LinksClose Window
References
Connick P, Kolappan M, Crawley C. et al.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Lancet Neurol 2012;
11: 150-156
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.